Brazil Enzymes Research
7 comprehensive market analysis studies and research reports on the Brazil Enzymes sector, offering an overview with historical data since 2019 and forecasts up to 2030. This includes a detailed market research of 132 companies, enriched with industry statistics, insights, and a lot more.
TRENDING REPORTS
Restriction Endonucleases Market
CAGR: 6.67%
Study Period : 2024 - 2030
Trypsin Market
CAGR: 5.51%
Study Period : 2020 - 2031
Healthcare
Categories
7 Healthcare Reports
Categories
Showing 7 of 7 results in Enzymes
Enzyme Replacement Therapy Market
CAGR: 8.99%
Study Period: 2020 - 2031
Country Covered: Brazil
Major Players:Sanofi, Takeda Pharmaceuticals, Biomarin Pharmaceutical, Amicus Therapeutics, Ultragenyx Pharmaceutical Inc.
Cytokine Market
CAGR: 7.08%
Study Period: 2020 - 2031
Country Covered: Brazil
Major Players:Abbvie, Novartis, Johnson & Johnson, Amgen, Roche
In-vitro Diagnostics Enzymes Market
CAGR: 7.80%
Study Period: 2019 - 2030
Country Covered: Brazil
Major Players:Thermo Fisher Scientific, QIAGEN , New England Biolabs, Merck, Takara Bio
TRENDING REPORTS
Restriction Endonucleases Market
CAGR: 6.67%
Study Period : 2024 - 2030
Trypsin Market
CAGR: 5.51%
Study Period : 2020 - 2031
Horseradish Peroxidase Market
CAGR: 8.5%
Study Period: 2019 - 2030
Country Covered: Brazil
Major Players:Merck, Thermo Fisher Scientific, BBI Solutions, Creative Enzymes, Promega
IVD Raw Materials Market
CAGR: 5.18%
Study Period: 2019 - 2030
Country Covered: Brazil
Major Players:Creative Diagnostics, Merck, Thermo Fisher Scientific, Roche, LGC Group
Ligases Enzyme Market
CAGR: 5.5%
Study Period: 2019 - 2030
Country Covered: Brazil
Major Players:Beckton Dickinson, Agilent Technologies, Merck, Thermo Fisher Scientific, ArcticZymes Technologies
Global Digestive Enzymes Market
CAGR: 8.3%
Study Period: 2019 - 2030
Country Covered: Brazil
Major Players:Abbvie, Biotics Research, Klaire Labs, Amway, Zeus Biotech
Yay! You have seen it all
CONTACT US
When decisions matter, industry leaders turn to our analysts. Let’s talk.
